ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Emcure launches Galact supplement for breastfeeding mothers in over-the-counter market

According to a press release, Galact, a lactation supplement designed to enhance breast milk production, has been prescribed by healthcare professionals for over two decades and will now be available as an OTC offering.

ANI Mar 12, 2024 17:01 IST googleads

Emcure Pharmaceuticals Ltd.

Mumbai (Maharashtra) [India], March 12 (ANI): Emcure Pharmaceuticals has announced its foray into the over-the-counter (OTC) market with the launch of its flagship product, Galact.
According to a press release, Galact, a lactation supplement designed to enhance breast milk production, has been prescribed by healthcare professionals for over two decades and will now be available as an OTC offering.
Formulated with a blend of natural ingredients including Shatavari and six other herbs, Galact is aimed at bolstering breast milk production in mothers.
Shatavari, a key component, not only aids in increasing milk supply but is also known for promoting baby's weight gain, improving sleep patterns, and boosting immunity.
Another vital ingredient, Yashtimadhu, contributes to enhancing cognitive functions, memory, and concentration, thereby potentially improving the baby's IQ.
The launch of Galact marks Emcure's initial step into the OTC segment, with plans to introduce a broader range of products addressing various aspects of women's health.
Namita Thapar, Whole-time Director at Emcure Pharmaceuticals, highlighted the company's commitment to advancing women's health solutions, stating, "Emcure has always focused on awareness, access, and affordability to strengthen women's health in India. The launch of Galact marks our efforts to redefine and further elevate the standard of women's health solutions. Our foray into the OTC segment focuses on empowering women across various life stages, starting with a portfolio tailored for their lactation journey."
Thapar added, "In India, only 64 per cent of mothers breastfeed their babies exclusively in the first 6 months. By making Galact available over the counter, Emcure aims to sensitise all mothers to practice exclusive breastfeeding for the first 6 months in line with the WHO and UNICEF breastfeeding guidelines. Emcure plans to introduce more products under the Galact brand."
Emcure Pharmaceuticals has a longstanding commitment to raising awareness about women's health issues such as anemia, menstruation, and breastfeeding.
With the introduction of the revamped Galact brand, the company aims to further its advocacy for breastfeeding and advocate for optimal nutrition for infants. (ANI)

Get the App

What to Read Next

Business

Avery Pharmaceuticals Show Innovative Nutraceutical Products

Avery Pharmaceuticals Show Innovative Nutraceutical Products

Mumbai (Maharashtra) [India], February 27: Avery Pharmaceuticals Pvt. Ltd. showcased its innovative Mouth Dissolving Strips and CDMO solutions at Vitafoods India 2026, held from February 11-13 at the Jio World Convention Centre in Mumbai. Over 500 visitors engaged with our booth, showcasing the robust interest from key players across the pharmaceutical, nutraceutical, and healthcare sectors. . The participation enabled the company to demonstrate its scientific capabilities, initiate new business conversations, and strengthen relationships with existing and prospective partners.

Read More
Business

Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB

Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB

Mumbai (Maharashtra) [India], February 25: Fredun Pharmaceuticals Limited (BSE - FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility, and animal healthcare products, has secured a credit rating upgrade from Infomerics Valuation and Rating Limited for its bank facilities aggregating to ₹156.17 crore.

Read More
Business

Boehringer Ingelheim India and NIPER Raebareli Sign MoU

Boehringer Ingelheim India and NIPER Raebareli Sign MoU

New Delhi [India], February 19: Boehringer Ingelheim India Private Limited today announced the signing of a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, including its Centre of Excellence for Novel Drug Delivery Systems (CoE-NDDS). The MoU was signed at the Department of Pharmaceuticals in the presence of Shri Manoj Joshi, IAS, Secretary, Department of Pharmaceuticals.

Read More
Business

From Ink to Intelligence - Powering India’s Next Phase

From Ink to Intelligence - Powering India’s Next Phase

New Delhi [India], February 17: India's manufacturing and packaging ecosystem is entering a new era defined by digital compliance, traceability, and structured regulatory enforcement. As government mandates expand across pharmaceuticals, FMCG, agrochemicals, food processing, extrusion, and industrial manufacturing, Coding and Marking technologies are evolving from basic statutory requirements into strategic infrastructure for national supply chain transparency. The increasing integration of data into product-level markings is reshaping how businesses manage accountability, authenticity and consumer trust.

Read More
Business

Dr. Basant Goel Honored with Two Prestigious National

Dr. Basant Goel Honored with Two Prestigious National

New Delhi [India], February 17: On 16 February 2026, Dr. Basant Goel was conferred with two distinguished honors--the U-N Book of World Records title and the Swabhiman Bharat Samman 2026--in recognition of his extraordinary contributions to humanitarian service, healthcare, and Gau Seva.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.